XOMAP Q4 2017 Earnings — XOMA Corporation Revenue & Financial Results | Market Cap Arena

XOMAPXOMA Corporation

$311M

Q4 2017 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$5M+922.3% YoY

Gross Profit

$5M87.7% margin

Operating Income

-$2M-37.5% margin

Net Income

-$1M-24.6% margin

EPS (Diluted)

$-0.12

QoQ Revenue Growth

-85.2%

Cash Flow

Operating Cash Flow

-$5M

Free Cash Flow

-$5M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$45M

Total Liabilities

$39M

Stockholders' Equity

$6M

Cash & Equivalents

$43M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$5M	$524,000	+922.3%
Gross Profit	$5M	-$34M	+113.8%
Operating Income	-$2M	-$17M	+88.5%
Net Income	-$1M	-$17M	+92.5%